Concomitant medication
bone pain
Patients received prophylactic antiemetics and premedications according to standard institutional guidelines. Colony stimulating growth factor use was allowed at the discretion of the treating physician. Palliative radiotherapy was permitted to control bone pain as long as the irradiated area was limited in extent. Other investigational agents and potent inhibitors or inducers of CYP3A4 were not permitted.